EMA is not yet established in Amsterdam or pharma companies are already in line to come to Amsterdam
September 22, 2018The first effects of the arrival of the European Medicines Agency EMA are already being felt.
The EMA effect is also good news for scientific research. Director Bart Klijsen of IXA VU-VUmc says, “In order to bring research to society, cooperation and participation with companies is indispensable. This requires a mature ecosystem. That is why the arrival of EMA is positive for the Netherlands and for the region. Although not all contacts are directly related to EMA, there is a lot more interest from the medical industry in Amsterdam.”
Read the full Parool article of Herman Stil, Artikel-Parool-Als-EMA-over-de-dam-is…..pdf
More news
MIT Feasibility subsidy for VU start-up PreActive to adopt AI in Welness app
VU start-up, PreActive, has been awarded the MIT Feasibility Study subsidy of € 20k from Provincie Noord-Holland! With this subsidy funding PreActive will explore the utility and feasibility of incorporating Artificial Intelligence within the PreActive wellness app to help improve & personalise the user experience. Feasibility study of the Wellness app The PreActive Wellness app […]
News
SusPhos received EU funding for upcycling solution
UvA spin-off SusPhos has been selected for the EIC Accelerator funding. They receive a grant and an equity investment from the EU fund for its game-changing solution for upcycling phosphate from waste streams into sustainable products. SusPhos, now based in Leeuwarden, aims to create “urban mines” in Europe to produce phosphate compounds out of waste. […]
News
Use of Smart ‘swimming cap’, directs people suffering a stroke to right hospital
A smart swimming cap with electrodes can diagnose a stroke in the ambulance, so that a patient receives the correct treatment more quickly.
News